🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
11.07
+0.04 (0.36%)
Nov 20, 2026, 4:00 PM EST - Market closed

MLTX Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
379.7334.52180.43451.1739.518.04
Short-Term Investments
118.7659.45267.659.8432.61-
Cash & Short-Term Investments
498.46393.97448.03511.0172.118.04
Cash Growth
31.01%-12.07%-12.32%608.60%797.08%-
Other Receivables
-4.872.841.060.220.15
Receivables
-4.872.841.060.220.15
Prepaid Expenses
25.9322.8623.422.14.181.45
Total Current Assets
533.34421.69474.29514.1776.519.64
Property, Plant & Equipment
2.162.143.643.950.330.05
Long-Term Deferred Charges
5.220.6----
Other Long-Term Assets
---8.42--
Total Assets
540.72424.43477.93526.5476.849.68

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
13.850.370.180.330.160.03
Accrued Expenses
42.9442.7920.278.077.244.76
Short-Term Debt
-----15
Current Portion of Leases
0.961.231.371.20.15-
Current Income Taxes Payable
0.681.090.640.370.110.06
Other Current Liabilities
-----1.23
Total Current Liabilities
58.4345.4822.469.977.6721.09
Long-Term Debt
100.0174.1----
Long-Term Leases
0.650.371.462.50.13-
Pension & Post-Retirement Benefits
--0.620.580.280.24
Total Liabilities
159.09119.9524.5413.058.0821.33

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010.04
Additional Paid-In Capital
1,053766.78677.42609.97129.1942.06
Retained Earnings
-673.97-462.91-235.59-116.66-80.65-53.64
Treasury Stock
------0.01
Comprehensive Income & Other
2.290.652.360.35-0.17
Total Common Equity
381.63304.48446.83495.6848.9-11.72
Minority Interest
--6.5717.8219.87-
Shareholders' Equity
381.63304.48453.39513.4968.77-11.65
Total Liabilities & Equity
540.72424.43477.93526.5476.849.68

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
101.6275.712.833.70.2815
Net Cash (Debt)
396.85318.26445.2507.3171.83-6.96
Net Cash Growth
30.22%-28.51%-12.24%606.24%--
Net Cash Per Share
5.314.947.0810.332.45-0.89
Filing Date Shares Outstanding
85.1171.7363.2862.8739.150.3
Total Common Shares Outstanding
85.1171.3763.0860.4738.980.3
Working Capital
474.91376.22451.83504.268.85-11.45
Book Value Per Share
4.484.277.088.201.25-38.57
Tangible Book Value
381.63304.48446.83495.6848.9-11.72
Tangible Book Value Per Share
4.484.277.088.201.25-38.57
SEC Filings: 10-K · 10-Q